HEADER TRANSFERASE/TRANSFERASE INHIBITOR 04-MAY-18 5ZTN TITLE THE CRYSTAL STRUCTURE OF HUMAN DYRK2 IN COMPLEX WITH CURCUMIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: DUAL SPECIFICITY TYROSINE-PHOSPHORYLATION-REGULATED KINASE COMPND 3 2; COMPND 4 CHAIN: A, B; COMPND 5 EC: 2.7.12.1; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: DYRK2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3) KEYWDS INHIBITOR OF KINASE, TRANSFERASE, TRANSFERASE-TRANSFERASE INHIBITOR KEYWDS 2 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR C.G.JI,J.Y.XIAO REVDAT 3 22-NOV-23 5ZTN 1 REMARK REVDAT 2 29-AUG-18 5ZTN 1 JRNL REVDAT 1 18-JUL-18 5ZTN 0 JRNL AUTH S.BANERJEE,C.JI,J.E.MAYFIELD,A.GOEL,J.XIAO,J.E.DIXON,X.GUO JRNL TITL ANCIENT DRUG CURCUMIN IMPEDES 26S PROTEASOME ACTIVITY BY JRNL TITL 2 DIRECT INHIBITION OF DUAL-SPECIFICITY TYROSINE-REGULATED JRNL TITL 3 KINASE 2. JRNL REF PROC. NATL. ACAD. SCI. V. 115 8155 2018 JRNL REF 2 U.S.A. JRNL REFN ESSN 1091-6490 JRNL PMID 29987021 JRNL DOI 10.1073/PNAS.1806797115 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.11.1_2575) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.28 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 35490 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.200 REMARK 3 R VALUE (WORKING SET) : 0.197 REMARK 3 FREE R VALUE : 0.244 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.610 REMARK 3 FREE R VALUE TEST SET COUNT : 1990 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 40.2803 - 6.0090 0.97 2376 144 0.1579 0.1962 REMARK 3 2 6.0090 - 4.7720 1.00 2425 137 0.1693 0.2016 REMARK 3 3 4.7720 - 4.1695 1.00 2404 141 0.1491 0.1884 REMARK 3 4 4.1695 - 3.7886 1.00 2378 147 0.1761 0.2078 REMARK 3 5 3.7886 - 3.5172 1.00 2416 142 0.2038 0.2384 REMARK 3 6 3.5172 - 3.3099 1.00 2398 146 0.2133 0.2572 REMARK 3 7 3.3099 - 3.1442 1.00 2392 143 0.2314 0.3028 REMARK 3 8 3.1442 - 3.0074 1.00 2380 140 0.2668 0.3629 REMARK 3 9 3.0074 - 2.8917 1.00 2380 142 0.2588 0.3611 REMARK 3 10 2.8917 - 2.7919 1.00 2389 141 0.2524 0.3096 REMARK 3 11 2.7919 - 2.7046 1.00 2400 145 0.2527 0.3349 REMARK 3 12 2.7046 - 2.6273 1.00 2377 135 0.2701 0.3513 REMARK 3 13 2.6273 - 2.5582 1.00 2424 146 0.2801 0.3153 REMARK 3 14 2.5582 - 2.4958 0.99 2361 141 0.3019 0.3741 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.370 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 30.870 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.009 6640 REMARK 3 ANGLE : 1.246 8942 REMARK 3 CHIRALITY : 0.057 922 REMARK 3 PLANARITY : 0.007 1158 REMARK 3 DIHEDRAL : 12.848 3986 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5ZTN COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 11-MAY-18. REMARK 100 THE DEPOSITION ID IS D_1300007645. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-OCT-16 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL17U1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.979 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RAYONIX MX-225 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 35490 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.496 REMARK 200 RESOLUTION RANGE LOW (A) : 40.275 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 7.100 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 21.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.50 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 3K2L REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.31 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.63 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M AMMONIUM CITRATE TRIBASIC, 12% REMARK 280 -20% PEG 3350,PH 7.0, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE REMARK 280 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 42 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -Y,X,Z+1/2 REMARK 290 4555 Y,-X,Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 74.56350 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 74.56350 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 51 REMARK 465 HIS A 52 REMARK 465 HIS A 53 REMARK 465 HIS A 54 REMARK 465 HIS A 55 REMARK 465 HIS A 56 REMARK 465 HIS A 57 REMARK 465 SER A 58 REMARK 465 SER A 59 REMARK 465 THR A 396 REMARK 465 LEU A 397 REMARK 465 SER A 398 REMARK 465 ASP A 399 REMARK 465 GLY A 400 REMARK 465 SER A 401 REMARK 465 VAL A 402 REMARK 465 ARG A 464 REMARK 465 ARG A 465 REMARK 465 LEU A 466 REMARK 465 PRO A 467 REMARK 465 LYS A 468 REMARK 465 PRO A 469 REMARK 465 PRO A 470 REMARK 465 THR A 471 REMARK 465 GLY A 472 REMARK 465 GLU A 473 REMARK 465 LYS A 474 REMARK 465 THR A 475 REMARK 465 SER A 476 REMARK 465 VAL A 477 REMARK 465 LYS A 478 REMARK 465 ARG A 479 REMARK 465 MET B 51 REMARK 465 HIS B 52 REMARK 465 HIS B 53 REMARK 465 HIS B 54 REMARK 465 HIS B 55 REMARK 465 HIS B 56 REMARK 465 HIS B 57 REMARK 465 SER B 58 REMARK 465 SER B 59 REMARK 465 THR B 396 REMARK 465 LEU B 397 REMARK 465 SER B 398 REMARK 465 ASP B 399 REMARK 465 GLY B 400 REMARK 465 SER B 401 REMARK 465 VAL B 402 REMARK 465 ARG B 464 REMARK 465 ARG B 465 REMARK 465 LEU B 466 REMARK 465 PRO B 467 REMARK 465 LYS B 468 REMARK 465 PRO B 469 REMARK 465 PRO B 470 REMARK 465 THR B 471 REMARK 465 GLY B 472 REMARK 465 GLU B 473 REMARK 465 LYS B 474 REMARK 465 THR B 475 REMARK 465 SER B 476 REMARK 465 VAL B 477 REMARK 465 LYS B 478 REMARK 465 ARG B 479 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 NH1 ARG B 305 O HOH B 601 2.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 OG1 THR B 122 O HIS B 303 2545 2.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 122 -70.20 -46.78 REMARK 500 ARG A 148 -39.11 -138.27 REMARK 500 LEU A 215 -60.48 -97.01 REMARK 500 LEU A 231 -145.41 -105.41 REMARK 500 SER A 232 -153.30 -126.93 REMARK 500 ASN A 242 20.13 -79.67 REMARK 500 ASP A 275 48.48 -150.67 REMARK 500 ASP A 295 74.14 55.37 REMARK 500 VAL A 306 -74.63 -122.97 REMARK 500 THR A 308 -71.19 -93.39 REMARK 500 PTR A 309 94.27 -67.54 REMARK 500 ALA A 375 39.55 -95.11 REMARK 500 ASP A 431 44.54 -108.11 REMARK 500 LEU A 443 37.37 -91.75 REMARK 500 ASN B 126 -95.16 -90.11 REMARK 500 ARG B 148 -40.14 -138.28 REMARK 500 LEU B 231 -145.87 -106.29 REMARK 500 SER B 232 -154.17 -127.21 REMARK 500 ASN B 242 20.74 -79.95 REMARK 500 ASP B 275 48.80 -150.84 REMARK 500 ASP B 295 73.44 54.62 REMARK 500 VAL B 306 -76.76 -128.21 REMARK 500 ALA B 375 38.38 -94.43 REMARK 500 ASP B 431 45.17 -108.52 REMARK 500 LEU B 443 38.68 -91.71 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 GLN B 304 ARG B 305 -139.67 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CUR A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CUR B 501 DBREF 5ZTN A 73 479 UNP Q92630 DYRK2_HUMAN 146 552 DBREF 5ZTN B 73 479 UNP Q92630 DYRK2_HUMAN 146 552 SEQADV 5ZTN MET A 51 UNP Q92630 EXPRESSION TAG SEQADV 5ZTN HIS A 52 UNP Q92630 EXPRESSION TAG SEQADV 5ZTN HIS A 53 UNP Q92630 EXPRESSION TAG SEQADV 5ZTN HIS A 54 UNP Q92630 EXPRESSION TAG SEQADV 5ZTN HIS A 55 UNP Q92630 EXPRESSION TAG SEQADV 5ZTN HIS A 56 UNP Q92630 EXPRESSION TAG SEQADV 5ZTN HIS A 57 UNP Q92630 EXPRESSION TAG SEQADV 5ZTN SER A 58 UNP Q92630 EXPRESSION TAG SEQADV 5ZTN SER A 59 UNP Q92630 EXPRESSION TAG SEQADV 5ZTN GLY A 60 UNP Q92630 EXPRESSION TAG SEQADV 5ZTN VAL A 61 UNP Q92630 EXPRESSION TAG SEQADV 5ZTN ASP A 62 UNP Q92630 EXPRESSION TAG SEQADV 5ZTN LEU A 63 UNP Q92630 EXPRESSION TAG SEQADV 5ZTN GLY A 64 UNP Q92630 EXPRESSION TAG SEQADV 5ZTN THR A 65 UNP Q92630 EXPRESSION TAG SEQADV 5ZTN GLU A 66 UNP Q92630 EXPRESSION TAG SEQADV 5ZTN ASN A 67 UNP Q92630 EXPRESSION TAG SEQADV 5ZTN LEU A 68 UNP Q92630 EXPRESSION TAG SEQADV 5ZTN TYR A 69 UNP Q92630 EXPRESSION TAG SEQADV 5ZTN PHE A 70 UNP Q92630 EXPRESSION TAG SEQADV 5ZTN GLN A 71 UNP Q92630 EXPRESSION TAG SEQADV 5ZTN SER A 72 UNP Q92630 EXPRESSION TAG SEQADV 5ZTN MET B 51 UNP Q92630 EXPRESSION TAG SEQADV 5ZTN HIS B 52 UNP Q92630 EXPRESSION TAG SEQADV 5ZTN HIS B 53 UNP Q92630 EXPRESSION TAG SEQADV 5ZTN HIS B 54 UNP Q92630 EXPRESSION TAG SEQADV 5ZTN HIS B 55 UNP Q92630 EXPRESSION TAG SEQADV 5ZTN HIS B 56 UNP Q92630 EXPRESSION TAG SEQADV 5ZTN HIS B 57 UNP Q92630 EXPRESSION TAG SEQADV 5ZTN SER B 58 UNP Q92630 EXPRESSION TAG SEQADV 5ZTN SER B 59 UNP Q92630 EXPRESSION TAG SEQADV 5ZTN GLY B 60 UNP Q92630 EXPRESSION TAG SEQADV 5ZTN VAL B 61 UNP Q92630 EXPRESSION TAG SEQADV 5ZTN ASP B 62 UNP Q92630 EXPRESSION TAG SEQADV 5ZTN LEU B 63 UNP Q92630 EXPRESSION TAG SEQADV 5ZTN GLY B 64 UNP Q92630 EXPRESSION TAG SEQADV 5ZTN THR B 65 UNP Q92630 EXPRESSION TAG SEQADV 5ZTN GLU B 66 UNP Q92630 EXPRESSION TAG SEQADV 5ZTN ASN B 67 UNP Q92630 EXPRESSION TAG SEQADV 5ZTN LEU B 68 UNP Q92630 EXPRESSION TAG SEQADV 5ZTN TYR B 69 UNP Q92630 EXPRESSION TAG SEQADV 5ZTN PHE B 70 UNP Q92630 EXPRESSION TAG SEQADV 5ZTN GLN B 71 UNP Q92630 EXPRESSION TAG SEQADV 5ZTN SER B 72 UNP Q92630 EXPRESSION TAG SEQRES 1 A 429 MET HIS HIS HIS HIS HIS HIS SER SER GLY VAL ASP LEU SEQRES 2 A 429 GLY THR GLU ASN LEU TYR PHE GLN SER MET GLY LYS VAL SEQRES 3 A 429 LYS ALA THR PRO MET THR PRO GLU GLN ALA MET LYS GLN SEQRES 4 A 429 TYR MET GLN LYS LEU THR ALA PHE GLU HIS HIS GLU ILE SEQRES 5 A 429 PHE SER TYR PRO GLU ILE TYR PHE LEU GLY LEU ASN ALA SEQRES 6 A 429 LYS LYS ARG GLN GLY MET THR GLY GLY PRO ASN ASN GLY SEQRES 7 A 429 GLY TYR ASP ASP ASP GLN GLY SER TYR VAL GLN VAL PRO SEQRES 8 A 429 HIS ASP HIS VAL ALA TYR ARG TYR GLU VAL LEU LYS VAL SEQRES 9 A 429 ILE GLY LYS GLY SER PHE GLY GLN VAL VAL LYS ALA TYR SEQRES 10 A 429 ASP HIS LYS VAL HIS GLN HIS VAL ALA LEU LYS MET VAL SEQRES 11 A 429 ARG ASN GLU LYS ARG PHE HIS ARG GLN ALA ALA GLU GLU SEQRES 12 A 429 ILE ARG ILE LEU GLU HIS LEU ARG LYS GLN ASP LYS ASP SEQRES 13 A 429 ASN THR MET ASN VAL ILE HIS MET LEU GLU ASN PHE THR SEQRES 14 A 429 PHE ARG ASN HIS ILE CYS MET THR PHE GLU LEU LEU SER SEQRES 15 A 429 MET ASN LEU TYR GLU LEU ILE LYS LYS ASN LYS PHE GLN SEQRES 16 A 429 GLY PHE SER LEU PRO LEU VAL ARG LYS PHE ALA HIS SER SEQRES 17 A 429 ILE LEU GLN CYS LEU ASP ALA LEU HIS LYS ASN ARG ILE SEQRES 18 A 429 ILE HIS CYS ASP LEU LYS PRO GLU ASN ILE LEU LEU LYS SEQRES 19 A 429 GLN GLN GLY ARG SER GLY ILE LYS VAL ILE ASP PHE GLY SEQRES 20 A 429 SER SER CYS TYR GLU HIS GLN ARG VAL TYR THR PTR ILE SEQRES 21 A 429 GLN SER ARG PHE TYR ARG ALA PRO GLU VAL ILE LEU GLY SEQRES 22 A 429 ALA ARG TYR GLY MET PRO ILE ASP MET TRP SER LEU GLY SEQRES 23 A 429 CYS ILE LEU ALA GLU LEU LEU THR GLY TYR PRO LEU LEU SEQRES 24 A 429 PRO GLY GLU ASP GLU GLY ASP GLN LEU ALA CYS MET ILE SEQRES 25 A 429 GLU LEU LEU GLY MET PRO SER GLN LYS LEU LEU ASP ALA SEQRES 26 A 429 SER LYS ARG ALA LYS ASN PHE VAL SER SEP LYS GLY TYR SEQRES 27 A 429 PRO ARG TYR CYS THR VAL THR THR LEU SER ASP GLY SER SEQRES 28 A 429 VAL VAL LEU ASN GLY GLY ARG SER ARG ARG GLY LYS LEU SEQRES 29 A 429 ARG GLY PRO PRO GLU SER ARG GLU TRP GLY ASN ALA LEU SEQRES 30 A 429 LYS GLY CYS ASP ASP PRO LEU PHE LEU ASP PHE LEU LYS SEQRES 31 A 429 GLN CYS LEU GLU TRP ASP PRO ALA VAL ARG MET THR PRO SEQRES 32 A 429 GLY GLN ALA LEU ARG HIS PRO TRP LEU ARG ARG ARG LEU SEQRES 33 A 429 PRO LYS PRO PRO THR GLY GLU LYS THR SER VAL LYS ARG SEQRES 1 B 429 MET HIS HIS HIS HIS HIS HIS SER SER GLY VAL ASP LEU SEQRES 2 B 429 GLY THR GLU ASN LEU TYR PHE GLN SER MET GLY LYS VAL SEQRES 3 B 429 LYS ALA THR PRO MET THR PRO GLU GLN ALA MET LYS GLN SEQRES 4 B 429 TYR MET GLN LYS LEU THR ALA PHE GLU HIS HIS GLU ILE SEQRES 5 B 429 PHE SER TYR PRO GLU ILE TYR PHE LEU GLY LEU ASN ALA SEQRES 6 B 429 LYS LYS ARG GLN GLY MET THR GLY GLY PRO ASN ASN GLY SEQRES 7 B 429 GLY TYR ASP ASP ASP GLN GLY SER TYR VAL GLN VAL PRO SEQRES 8 B 429 HIS ASP HIS VAL ALA TYR ARG TYR GLU VAL LEU LYS VAL SEQRES 9 B 429 ILE GLY LYS GLY SER PHE GLY GLN VAL VAL LYS ALA TYR SEQRES 10 B 429 ASP HIS LYS VAL HIS GLN HIS VAL ALA LEU LYS MET VAL SEQRES 11 B 429 ARG ASN GLU LYS ARG PHE HIS ARG GLN ALA ALA GLU GLU SEQRES 12 B 429 ILE ARG ILE LEU GLU HIS LEU ARG LYS GLN ASP LYS ASP SEQRES 13 B 429 ASN THR MET ASN VAL ILE HIS MET LEU GLU ASN PHE THR SEQRES 14 B 429 PHE ARG ASN HIS ILE CYS MET THR PHE GLU LEU LEU SER SEQRES 15 B 429 MET ASN LEU TYR GLU LEU ILE LYS LYS ASN LYS PHE GLN SEQRES 16 B 429 GLY PHE SER LEU PRO LEU VAL ARG LYS PHE ALA HIS SER SEQRES 17 B 429 ILE LEU GLN CYS LEU ASP ALA LEU HIS LYS ASN ARG ILE SEQRES 18 B 429 ILE HIS CYS ASP LEU LYS PRO GLU ASN ILE LEU LEU LYS SEQRES 19 B 429 GLN GLN GLY ARG SER GLY ILE LYS VAL ILE ASP PHE GLY SEQRES 20 B 429 SER SER CYS TYR GLU HIS GLN ARG VAL TYR THR PTR ILE SEQRES 21 B 429 GLN SER ARG PHE TYR ARG ALA PRO GLU VAL ILE LEU GLY SEQRES 22 B 429 ALA ARG TYR GLY MET PRO ILE ASP MET TRP SER LEU GLY SEQRES 23 B 429 CYS ILE LEU ALA GLU LEU LEU THR GLY TYR PRO LEU LEU SEQRES 24 B 429 PRO GLY GLU ASP GLU GLY ASP GLN LEU ALA CYS MET ILE SEQRES 25 B 429 GLU LEU LEU GLY MET PRO SER GLN LYS LEU LEU ASP ALA SEQRES 26 B 429 SER LYS ARG ALA LYS ASN PHE VAL SER SEP LYS GLY TYR SEQRES 27 B 429 PRO ARG TYR CYS THR VAL THR THR LEU SER ASP GLY SER SEQRES 28 B 429 VAL VAL LEU ASN GLY GLY ARG SER ARG ARG GLY LYS LEU SEQRES 29 B 429 ARG GLY PRO PRO GLU SER ARG GLU TRP GLY ASN ALA LEU SEQRES 30 B 429 LYS GLY CYS ASP ASP PRO LEU PHE LEU ASP PHE LEU LYS SEQRES 31 B 429 GLN CYS LEU GLU TRP ASP PRO ALA VAL ARG MET THR PRO SEQRES 32 B 429 GLY GLN ALA LEU ARG HIS PRO TRP LEU ARG ARG ARG LEU SEQRES 33 B 429 PRO LYS PRO PRO THR GLY GLU LYS THR SER VAL LYS ARG MODRES 5ZTN PTR A 309 TYR MODIFIED RESIDUE MODRES 5ZTN SEP A 385 SER MODIFIED RESIDUE MODRES 5ZTN PTR B 309 TYR MODIFIED RESIDUE MODRES 5ZTN SEP B 385 SER MODIFIED RESIDUE HET PTR A 309 16 HET SEP A 385 10 HET PTR B 309 16 HET SEP B 385 10 HET CUR A 501 27 HET CUR B 501 27 HETNAM PTR O-PHOSPHOTYROSINE HETNAM SEP PHOSPHOSERINE HETNAM CUR (1Z,4Z,6E)-5-HYDROXY-1,7-BIS(4-HYDROXY-3- HETNAM 2 CUR METHOXYPHENYL)HEPTA-1,4,6-TRIEN-3-ONE HETSYN PTR PHOSPHONOTYROSINE HETSYN SEP PHOSPHONOSERINE HETSYN CUR CURCUMIN, ENOL FORM FORMUL 1 PTR 2(C9 H12 N O6 P) FORMUL 1 SEP 2(C3 H8 N O6 P) FORMUL 3 CUR 2(C21 H20 O6) FORMUL 5 HOH *36(H2 O) HELIX 1 AA1 ASP A 62 GLU A 66 5 5 HELIX 2 AA2 THR A 82 MET A 91 1 10 HELIX 3 AA3 GLN A 92 LEU A 94 5 3 HELIX 4 AA4 THR A 95 ILE A 102 1 8 HELIX 5 AA5 PHE A 103 TYR A 105 5 3 HELIX 6 AA6 ASN A 126 TYR A 130 5 5 HELIX 7 AA7 GLU A 183 LYS A 202 1 20 HELIX 8 AA8 ASN A 234 ASN A 242 1 9 HELIX 9 AA9 SER A 248 ARG A 270 1 23 HELIX 10 AB1 LYS A 277 GLU A 279 5 3 HELIX 11 AB2 SER A 312 ARG A 316 5 5 HELIX 12 AB3 ALA A 317 GLY A 323 1 7 HELIX 13 AB4 MET A 328 GLY A 345 1 18 HELIX 14 AB5 ASP A 353 GLY A 366 1 14 HELIX 15 AB6 SER A 369 ALA A 375 1 7 HELIX 16 AB7 ARG A 378 PHE A 382 5 5 HELIX 17 AB8 GLU A 422 LEU A 427 1 6 HELIX 18 AB9 ASP A 432 LEU A 443 1 12 HELIX 19 AC1 THR A 452 ARG A 458 1 7 HELIX 20 AC2 ASP B 62 GLU B 66 5 5 HELIX 21 AC3 THR B 82 MET B 91 1 10 HELIX 22 AC4 GLN B 92 LEU B 94 5 3 HELIX 23 AC5 THR B 95 ILE B 102 1 8 HELIX 24 AC6 PHE B 103 TYR B 105 5 3 HELIX 25 AC7 GLU B 183 LYS B 202 1 20 HELIX 26 AC8 ASN B 234 ASN B 242 1 9 HELIX 27 AC9 SER B 248 ARG B 270 1 23 HELIX 28 AD1 LYS B 277 GLU B 279 5 3 HELIX 29 AD2 SER B 312 ARG B 316 5 5 HELIX 30 AD3 ALA B 317 LEU B 322 1 6 HELIX 31 AD4 MET B 328 GLY B 345 1 18 HELIX 32 AD5 ASP B 353 GLY B 366 1 14 HELIX 33 AD6 SER B 369 ALA B 375 1 7 HELIX 34 AD7 ARG B 378 PHE B 382 5 5 HELIX 35 AD8 GLU B 422 LEU B 427 1 6 HELIX 36 AD9 ASP B 432 LEU B 443 1 12 HELIX 37 AE1 THR B 452 ARG B 458 1 7 SHEET 1 AA1 2 ASN A 67 TYR A 69 0 SHEET 2 AA1 2 LYS A 77 THR A 79 -1 O LYS A 77 N TYR A 69 SHEET 1 AA2 6 HIS A 144 VAL A 145 0 SHEET 2 AA2 6 TYR A 149 LYS A 157 -1 O TYR A 149 N VAL A 145 SHEET 3 AA2 6 GLY A 161 ASP A 168 -1 O VAL A 163 N GLY A 156 SHEET 4 AA2 6 GLN A 173 VAL A 180 -1 O VAL A 175 N ALA A 166 SHEET 5 AA2 6 HIS A 223 GLU A 229 -1 O MET A 226 N LYS A 178 SHEET 6 AA2 6 MET A 214 PHE A 220 -1 N PHE A 218 O CYS A 225 SHEET 1 AA3 2 ILE A 271 ILE A 272 0 SHEET 2 AA3 2 CYS A 300 TYR A 301 -1 O CYS A 300 N ILE A 272 SHEET 1 AA4 2 ILE A 281 LEU A 283 0 SHEET 2 AA4 2 ILE A 291 VAL A 293 -1 O LYS A 292 N LEU A 282 SHEET 1 AA5 2 ASN B 67 TYR B 69 0 SHEET 2 AA5 2 LYS B 77 THR B 79 -1 O LYS B 77 N TYR B 69 SHEET 1 AA6 6 HIS B 144 VAL B 145 0 SHEET 2 AA6 6 TYR B 149 LYS B 157 -1 O TYR B 149 N VAL B 145 SHEET 3 AA6 6 GLY B 161 ASP B 168 -1 O LYS B 165 N LYS B 153 SHEET 4 AA6 6 GLN B 173 VAL B 180 -1 O GLN B 173 N ASP B 168 SHEET 5 AA6 6 HIS B 223 GLU B 229 -1 O MET B 226 N LYS B 178 SHEET 6 AA6 6 MET B 214 PHE B 220 -1 N PHE B 218 O CYS B 225 SHEET 1 AA7 2 ILE B 271 ILE B 272 0 SHEET 2 AA7 2 CYS B 300 TYR B 301 -1 O CYS B 300 N ILE B 272 SHEET 1 AA8 2 ILE B 281 LEU B 283 0 SHEET 2 AA8 2 ILE B 291 VAL B 293 -1 O LYS B 292 N LEU B 282 LINK C THR A 308 N PTR A 309 1555 1555 1.32 LINK C PTR A 309 N ILE A 310 1555 1555 1.34 LINK C SER A 384 N SEP A 385 1555 1555 1.33 LINK C SEP A 385 N LYS A 386 1555 1555 1.33 LINK C THR B 308 N PTR B 309 1555 1555 1.33 LINK C PTR B 309 N ILE B 310 1555 1555 1.34 LINK C SER B 384 N SEP B 385 1555 1555 1.33 LINK C SEP B 385 N LYS B 386 1555 1555 1.33 SITE 1 AC1 16 LYS A 153 ILE A 155 PHE A 160 ALA A 176 SITE 2 AC1 16 LYS A 178 GLU A 193 PHE A 228 GLU A 229 SITE 3 AC1 16 LEU A 230 LEU A 231 SER A 232 LEU A 282 SITE 4 AC1 16 ILE A 294 ASP A 295 PHE A 296 GLY A 297 SITE 1 AC2 12 PHE B 160 ALA B 176 LYS B 178 GLU B 193 SITE 2 AC2 12 PHE B 228 GLU B 229 LEU B 230 LEU B 231 SITE 3 AC2 12 SER B 232 LEU B 282 ASP B 295 PHE B 296 CRYST1 83.659 83.659 149.127 90.00 90.00 90.00 P 42 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011953 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011953 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006706 0.00000